KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) FCF Margin (2018 - 2025)

BioNTech SE's FCF Margin history spans 8 years, with the latest figure at 1004.58% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 100459.0% to 1004.58% in Q4 2025 year-over-year; TTM through Dec 2025 was 14.22%, a 1425.0% decrease, with the full-year FY2025 number at 21.99%, down 44424.0% from a year prior.
  • FCF Margin hit 1004.58% in Q4 2025 for BioNTech SE, up from 2.36% in the prior quarter.
  • Over the last five years, FCF Margin for BNTX hit a ceiling of 2655.87% in Q2 2023 and a floor of 3154.31% in Q1 2025.
  • Historically, FCF Margin has averaged 130.53% across 5 years, with a median of 24.34% in 2021.
  • Biggest five-year swings in FCF Margin: soared 253106bps in 2023 and later crashed -301636bps in 2025.
  • Tracing BNTX's FCF Margin over 5 years: stood at 2.89% in 2021, then surged by 880bps to 22.57% in 2022, then skyrocketed by 180bps to 63.2% in 2023, then plummeted by -100bps to 0.01% in 2024, then surged by 8356846bps to 1004.58% in 2025.
  • Business Quant data shows FCF Margin for BNTX at 1004.58% in Q4 2025, 2.36% in Q3 2025, and 347.44% in Q2 2025.